Discover the latest advancements in osteoporosis treatment for postmenopausal women. New medications, including Romosozumab and Denosumab, offer hope and convenience, promising better bone health and ...
fracture risk reductions were similar for patients taking glucocorticoids as for women with postmenopausal osteoporosis. The current model implicitly used these same assumptions. The relative ...
Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...